Paul Gisbert Auwaerter - Net Worth and Insider Trading
Paul Gisbert Auwaerter Net Worth
The estimated net worth of Paul Gisbert Auwaerter is at least $70,400 dollars as of 2024-12-29. Paul Gisbert Auwaerter is the Director of Capricor Therapeutics Inc and owns about 5,000 shares of Capricor Therapeutics Inc (CAPR) stock worth over $70,400. Details can be seen in Paul Gisbert Auwaerter's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Gisbert Auwaerter has not made any transactions after 2023-10-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Gisbert Auwaerter
Paul Gisbert Auwaerter Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Gisbert Auwaerter owns 1 companies in total, including Capricor Therapeutics Inc (CAPR) .
Click here to see the complete history of Paul Gisbert Auwaerter’s form 4 insider trades.
Insider Ownership Summary of Paul Gisbert Auwaerter
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CAPR | Capricor Therapeutics Inc | 2023-10-06 | director |
Paul Gisbert Auwaerter Latest Holdings Summary
Paul Gisbert Auwaerter currently owns a total of 1 stock. Paul Gisbert Auwaerter owns 5,000 shares of Capricor Therapeutics Inc (CAPR) as of October 6, 2023, with a value of $70,400.
Latest Holdings of Paul Gisbert Auwaerter
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CAPR | Capricor Therapeutics Inc | 2023-10-06 | 5,000 | 14.08 | 70,400 |
Holding Weightings of Paul Gisbert Auwaerter
Paul Gisbert Auwaerter Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Gisbert Auwaerter has made a total of 1 transactions in Capricor Therapeutics Inc (CAPR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Capricor Therapeutics Inc is the acquisition of 5,000 shares on October 6, 2023, which cost Paul Gisbert Auwaerter around $14,200.
Insider Trading History of Paul Gisbert Auwaerter
- 1
Paul Gisbert Auwaerter Trading Performance
GuruFocus tracks the stock performance after each of Paul Gisbert Auwaerter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Gisbert Auwaerter is 87.24%. GuruFocus also compares Paul Gisbert Auwaerter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Gisbert Auwaerter within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul Gisbert Auwaerter's insider trading performs compared to the benchmark.
Performance of Paul Gisbert Auwaerter
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.55 | | | | | |
| Relative Return to S&P 500(%) | -2.88 | | | | | |
Paul Gisbert Auwaerter Ownership Network
Paul Gisbert Auwaerter Owned Company Details
What does Capricor Therapeutics Inc do?
Who are the key executives at Capricor Therapeutics Inc?
Paul Gisbert Auwaerter is the director of Capricor Therapeutics Inc. Other key executives at Capricor Therapeutics Inc include CHIEF BUSINESS OFFICER Xavier Avat , director & CHIEF EXECUTIVE OFFICER Linda Marban , and EVP & GENERAL COUNSEL Karen Krasney .
Capricor Therapeutics Inc (CAPR) Insider Trades Summary
Over the past 18 months, Paul Gisbert Auwaerter made 1 insider transaction in Capricor Therapeutics Inc (CAPR) with a net purchase of 5,000. Other recent insider transactions involving Capricor Therapeutics Inc (CAPR) include a net purchase of 7,993 shares made by David B Musket , a net purchase of 2,798,507 shares made by , and a net purchase of 10,000 shares made by Collier Earl M Jr .
In summary, during the past 3 months, insiders sold 0 shares of Capricor Therapeutics Inc (CAPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Capricor Therapeutics Inc (CAPR) were sold and 2,821,500 shares were bought by its insiders, resulting in a net purchase of 2,821,500 shares.
Capricor Therapeutics Inc (CAPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Capricor Therapeutics Inc Insider Transactions
Paul Gisbert Auwaerter Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Gisbert Auwaerter. You might contact Paul Gisbert Auwaerter via mailing address: C/o Capricor Therapeutics, Inc., 10865 Road To The Cure, Suite 150, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
